Literature DB >> 1627720

Progress in assessing the quality of Australian nursing home care.

V Braithwaite1, J Braithwaite, D Gibson, T Makkai.   

Abstract

This paper critically examines the clarity, practicality, desirability and validity of the 31 outcome standards that the Commonwealth Government introduced to assess quality of care in Australian nursing homes. Key features of the Australian system in an international context are its focus on outcomes, the limited number of standards used, and the comparatively subjective nature of some standards. Directors of nursing from 410 nursing homes in the Brisbane, Sydney, Melbourne and Adelaide metropolitan areas were interviewed as part of the Nursing Home Regulation in Action Project. The overwhelming majority reported the standards as clear and desirable. In the minority of cases where problems were raised, practicability was the basis for concern. A factor analysis of the ratings given by standards monitoring teams to these 410 homes failed to demonstrate redundancy across standards or grouping of standards by objectives. Nevertheless, the standards were sufficiently highly interrelated to justify summing to produce an overall compliance score. This study shows that the 31 standards hold up well under scrutiny, both from the perspectives of key actors in the monitoring process, and from a psychometric point of view.

Mesh:

Year:  1992        PMID: 1627720     DOI: 10.1111/j.1753-6405.1992.tb00032.x

Source DB:  PubMed          Journal:  Aust J Public Health        ISSN: 1035-7319


  2 in total

1.  Relationship between regulatory status, quality of care, and three-year mortality in Canadian residential care facilities: a longitudinal study.

Authors:  Gina Bravo; Marie-France Dubois; Philippe De Wals; Réjean Hébert; Lise Messier
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

2.  Quality of care in unlicensed homes for the aged in the eastern townships of Quebec.

Authors:  G Bravo; M F Dubois; M Charpentier; P De Wals; A Emond
Journal:  CMAJ       Date:  1999-05-18       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.